Maitotoxin activates an endogenous non-selective cation channel and is an effective initiator of the activation of the heterologously expressed hTRPC-1 (transient receptor potential) non-selective cation channel in H4-IIE liver cells  by Brereton, Helen M et al.
Maitotoxin activates an endogenous non-selective cation channel and is
an e¡ective initiator of the activation of the heterologously expressed
hTRPC-1 (transient receptor potential) non-selective cation channel in
H4-IIE liver cells
Helen M. Brereton a, Jinglong Chen a, Grigori Rychkov b, M. Lyn Harland a,
Gregory J. Barritt a;*
a Department of Medical Biochemistry, School of Medicine, Flinders University, G.P.O. Box 2100, Adelaide, SA 5001, Australia
b Centre for Advanced Biomedical Studies, University of South Australia and Department of Physiology, University of Adelaide,
G.P.O. Box 498, Adelaide, SA 5001, Australia
Received 19 June 2000; received in revised form 28 May 2001; accepted 29 May 2001
Abstract
The structures and mechanisms of activation of non-selective cation channels (NSCCs) are not well understood although
NSCCs play important roles in the regulation of metabolism, ion transport, cell volume and cell shape. It has been proposed
that TRP (transient receptor potential) proteins are the molecular correlates of some NSCCs. Using fura-2 and patch-clamp
recording, it was shown that the maitotoxin-activated cation channels in the H4-IIE rat liver cell line admit Ca2, Mn2 and
Na, have a high selectivity for Na compared with Ca2, and are inhibited by Gd3 (half-maximal inhibition at 1 WM).
Activation of the channels by maitotoxin was inhibited by increasing the extracellular Ca2 concentration or by inclusion of
10 mM EGTA in the patch pipette. mRNA encoding TRP proteins 1, 2 and 3 at levels comparable with those in brain was
detected using reverse transcriptase^polymerase chain reaction in poly(A) RNA prepared from H4-IIE cells and freshly-
isolated rat hepatocytes. In H4-IIE cells transiently transfected with cDNA encoding hTRPC-1, the expressed hTRPC-1
protein was chiefly located at intracellular sites and at the plasma membrane. Cells expressing hTRPC-1 exhibited a
substantial enhancement of maitotoxin-initiated Ca2 inflow and a modest enhancement of thapsigargin-initiated Ca2
inflow (measured using fura-2) and no enhancement of the highly Ca2-selective store-operated Ca2 current (measured
using patch-clamp recording). In cells expressing hTRPC-1, maitotoxin activated channels which were not found in
untransfected cells, have an approximately equal selectivity for Na and Ca2, and are inhibited by Gd3 (half-maximal
inhibition at 3 WM). It is concluded that in liver cells (i) maitotoxin initiates the activation of endogenous NSCCs with a high
selectivity for Na compared with Ca2 ; (ii) TRP proteins 1, 2 and 3 are expressed; (iii) maitotoxin is an effective initiator of
activation of heterologously expressed hTRPC-1 channels; and (iv) the endogenous TRP-1 protein is unlikely to be the
molecular counterpart of the maitotoxin-activated NSCCs nor the highly Ca2-selective store-operated Ca2
channels. ß 2001 Elsevier Science B.V. All rights reserved.
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1. Introduction
Freshly isolated rat hepatocytes and rat liver cell
lines possess two main types of plasma membrane
Ca2 channels which are activated by the binding
of a hormone or growth factor to its receptor on
the plasma membrane. These are the Ca2 selective
store-operated Ca2 channels (also called Ca2 re-
lease-activated Ca2 channels) the activation of
which is initiated by a decrease in Ca2 in the endo-
plasmic reticulum, and intracellular messenger-acti-
vated non-selective cation channels (NSCCs) (re-
viewed in [1^4]). The physiological functions of
liver cell NSCCs are not well de¢ned but may include
the delivery of Ca2 to speci¢c regions of the cyto-
plasmic space, a contribution to the replenishment of
Ca2 in the endoplasmic reticulum, and the facilita-
tion of Na in£ow. Subsequent changes in [Ca2]cyt
and in the concentration of intracellular Na may
contribute to the regulation of liver cell metabolism,
ion £ow, cell volume and shape [1,5,6].
Several types of NSCCs have been identi¢ed in
liver cells. These include channels activated by hor-
mones, extracellular ATP, stretch, cyclic AMP (re-
viewed in [1^5]) and by the marine toxin, maitotoxin
[7]. Maitotoxin, a polycyclic ether isolated from the
marine dino£agellate Gambierdiscus toxicus, activates
NSCCs in many types of animal cells [7^13]. The
mechanism(s) by which maitotoxin activates NSCCs
is not well understood [11,13]. It most likely involves
the binding of the toxin to a speci¢c protein in the
plasma membrane and the subsequent activation of
an NSCC [13]. However, another possibility is that
the hydrophobic polycyclic ethers moieties of maito-
toxin are inserted into the plasma membrane to cre-
ate a non-speci¢c pore which admits Na and Ca2
to the cytoplasmic space [11]. It is proposed that
either of these events, in turn, leads to depolarisation
of the plasma membrane and an increase in
[Ca2]cyt ; activation of voltage-operated Ca2 chan-
nels (if present); activation of Ca2-dependent en-
zymes such as phospholipase C (which catalyses the
formation of Ins(1,4,5)P3); and the activation of
NSCCs and other plasma membrane channels. Mai-
totoxin-induced increases in [Ca2]cyt and intracellu-
lar Na concentration may also lead to the forma-
tion of arachidonic acid and other metabolites which
may, under some conditions, mediate the formation
of large cytolytic pores, additional in£ow of ions and
cell lysis [8,14].
The structures and mechanisms of activation of
NSCCs are not well understood [6]. However, there
is evidence that members of the TRP (transient re-
ceptor potential) family of proteins may be the mo-
lecular counterparts of some NSCCs [6,15,16]. The
animal cell TRP proteins are homologues of the Dro-
sophila melanogaster TRP and TRP-like (TRPL) pro-
teins which form non-selective cation channels in
the Drosophila photoreceptor cell (reviewed in
[6,15,16]).
The aims of the present experiments were to elu-
cidate the properties of the maitotoxin-activated
NSCCs in liver cells using the H4-IIE rat liver cell
line (derived from the Reuber hepatoma [3]), to in-
vestigate which TRP proteins are expressed in liver
cells, and to test whether a TRP protein is the mo-
lecular counterpart of maitotoxin-activated NSCCs.
The results indicate that maitotoxin initiates the ac-
tivation of Gd3 sensitive NSCCs which principally
admit Na. Moreover, mRNA encoding each of the
TRP proteins 1, 2 and 3 was detected in H4-IIE cells
and in freshly isolated rat hepatocytes. Heterologous
expression of the hTRPC-1 protein was found to be
associated with a substantial enhancement of maito-
toxin-stimulated Ca2, Mn2, and Na in£ow
through channels which were not detected in control
cells. It is concluded that maitotoxin initiates the
activation of endogenous NSCCs, and is an e¡ective
initiator of the activation of the heterologously ex-
pressed hTRPC-1 protein, but that it is unlikely that
the endogenous TRP-1 protein is the molecular
counterpart of the endogenous maitotoxin-activated
NSCCs.
2. Materials and methods
2.1. Materials
Maitotoxin was obtained from Sigma-Aldrich and
cDNA encoding human (h)TRPC-1 in the expression
vector pcDNA3 was kindly provided by Dr. C. Mon-
tell [17]. The sources of other reagents are as de-
scribed below or previously [3,18].
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2.2. Cell culture
The growth and sub-culture of H4-IIE cells (de-
rived from a rat liver hepatoma) were performed as
described previously [3,18]. AML12 mouse hepato-
cytes (ATCC CRL 2254), previously derived from
mice transgenic for transforming growth factor K
[19], were cultured at 37‡C in 5% (v/v) CO2 in air
in Dulbecco’s modi¢ed Eagle’s medium (DMEM)/
Ham’s F12 nutrient mixture (Life Technologies) sup-
plemented with 10% (v/v) foetal bovine serum, a mix-
ture of insulin, transferrin and selenium (ITS) (Life
Technologies), 0.1 WM dexamethasone, and 50 Wg/ml
gentamycin. H4-IIE and AML12 cells were subcul-
tured for a maximum of 20 passages. Rat hepato-
cytes were isolated from rat liver by collagenase per-
fusion and grown in primary culture as described
previously [18].
2.3. Molecular biology techniques
mRNA was prepared directly from rat hepatocytes
(4U106 cells) grown overnight in primary culture,
from cultured H4-IIE and AML12 cells (4U106
cells), and from freshly isolated rat brain (200 mg)
using Oligo (dT)25 magnetic beads (1 mg) (Dynal AS,
Oslo, Norway) according to the manufacturer’s in-
structions [20].
First-strand cDNA synthesis was conducted at
42‡C for 75 min using 1 Wg mRNA in a reaction
mixture (25 Wl total volume) which contained 200
units of Superscript II reverse transcriptase (RT),
40 units of RNase inhibitor, 1 mM dNTPs, 8.6
pmol oligo(dT)17 adaptor primer, 10 mM dithiothrei-
tol, 50 mM Tris^HCl (pH 8.0), 75 mM KCl and
3 mM MgCl2 [21]. Ampli¢cation of cDNA (2-Wl ali-
quots) was carried out in a reaction mixture (25 Wl
total volume) which contained 100 WM dNTP, 2 mM
MgCl2, 0.3 WM of each primer (except for the degen-
erate primer MTA which was used at 1 WM) and
0.6 units of Taq DNA polymerase. Reactions
were incubated for 30 s at 94‡C, 30 s at 55‡C and
1 min at 72‡C, for 45 cycles. Polymerase chain reac-
tion (PCR) products were size-fractionated on 1.5%
agarose gel and visualised by staining with ethidium
bromide.
In order to amplify cDNA encoding TRP proteins
1^6, a common 8-fold degenerate antisense primer
was employed. This was based on the highly con-
served sequence in the predicted cytoplasmic region
which is located next to the 3P end of the sixth trans-
membrane segment in the Drosophila TRP and
TRPL, human (h) TRP-1, and mouse (m) TRP-4
sequences [22^25]. Six speci¢c sense primers (corre-
sponding to TRP-1 to TRP-6) were based on the
sequences of the mTRP fragments identi¢ed by Pe-
tersen et al. [25] and Zhu et al. [26]. Each sense prim-
er was used in conjunction with the common anti-
sense primer. The quality of the cDNA synthesised
from each mRNA preparation was assessed by am-
pli¢cation using primers speci¢c for glyceraldehyde
3-phosphate dehydrogenase [27]. The primer sequen-
ces and expected sizes of the PCR products are listed
in Table 1.
The relative abundance of a given cDNA tran-
script obtained from di¡erent cell types was esti-
mated by a strategy of limiting dilution PCR [18].
After synthesis of the cDNA, an aliquot of the reac-
tion mixture was serially diluted in the range 1:5 to
1:100 000 and ampli¢ed as described above. The di-
lutions shown in Table 4 are the highest dilution
from which it was possible to amplify PCR product
that could be detected by ethidium bromide staining
of the agarose gel. This limiting dilution procedure
allows comparisons to be made between ampli¢ca-
tions obtained from di¡erent cell types using the
same primer set and conditions. However, it does
not allow comparisons to be made between PCR
products ampli¢ed using di¡erent primer sets.
For DNA sequencing, individual bands of PCR
product were excised from the 1.5% agarose gel
and the recovered DNA sequenced directly [21].
For con¢rmation of the sequence, all cDNA species
were prepared at least twice using di¡erent cell prep-
arations. All sequence data were obtained using the
DyeDeoxyT Terminator Cycle Sequencing kit and
the 373A automated DNA sequencer (Applied Bio-
systems, Prism, CA). Sequence comparisons were
performed with MacVector software, Version 5 (Ox-
ford Molecular Inc., MD).
2.4. Transfection of H4-IIE cells with cDNA encoding
green £uorescent protein and hTRPC-1
Cells were co-transfected [21] with cDNA encoding
hTRPC-1 plus pEGFP-C1 (Clontech), which con-
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tains cDNA encoding an enhanced green £uorescent
protein (EGFP). This allowed the selection of trans-
fected cells on the basis of their expression of GFP.
Control cells were transfected with either pEGFP-C1
alone or with pEGFP-C1 plus the empty pcDNA3
vector lacking the hTRPC-1 cDNA. Cells were trans-
fected using Fugene-6 transfection reagent (Roche
Diagnostics Australia, NSW, Australia) according
to the manufacturer’s protocol. Cells (2U105) were
suspended in 0.5 ml of antibiotic-free DMEM,
treated with a mixture containing 3 Wg hTRPC-1
cDNA, 0.3 Wg pEGFP-C1 and 6 Wl of Fugene-6 in
serum- and antibiotic-free DMEM, and plated onto
a collagen-coated coverslip. After 6 h, a further 1.5
ml of antibiotic-free DMEM was added and the cells
were cultured for a further 18^22 h to permit protein
expression before measurement of the amount of ex-
pressed hTRPC-1 protein and cation in£ow.
2.5. Antibody synthesis and puri¢cation, preparation
of cell lysates and Western blot analysis
An anti-TRP-1 antibody against the peptide,
CRDLLGFRTSKYAMFYPRN, which corresponds
to the 18 amino acids at the carboxy terminus of the
mouse (m), human (h), bovine (b), and Xenopus lae-
vis TRP-1 proteins (GenBank U73625, U31110,
AF012900, AF127031, respectively) was raised in
rabbits and puri¢ed by a⁄nity chromatography as
described previously [28].
Whole-cell protein extracts were prepared as fol-
lows. H4-IIE cells (20U106 cells) were harvested by
trypsinisation, washed twice with phosphate-bu¡ered
saline (PBS), suspended in Lysis Bu¡er (500 Wl)
which consisted of 50 mM Tris^HCl (pH 7.5),
1 mM EDTA, 10 WM leupeptin, 10 WM pepstatin,
100 WM phenylmethylsulphonyl £uoride, 1 mM
L-mercaptoethanol, 1% (v/v) Triton X-100 and
0.1% (w/v) sodium dodecyl sulphate (SDS), and in-
cubated for 30 min at 4‡C. Cell debris was removed
by centrifugation at 1000Ug for 5 min at 4‡C and
samples of the supernatant used for Western blot
analysis. A crude cellular membrane fraction was
prepared as described previously [28] using the Lysis
Bu¡er described above except that Triton X-100 and
SDS were omitted. H4-IIE cells were disrupted by
homogenisation (Ultra-turrax, 30 s) followed by son-
ication (Branson B-12 Soni¢er, microtip, 30 s) at
0‡C. Cell debris was removed by centrifugation at
1000Ug for 5 min at 4‡C. The resulting supernatant
was then centrifuged at 50 000Ug for 30 min at 4‡C
to yield crude membrane (the precipitate) and cyto-
solic (the supernatant) fractions. The membrane frac-
tion was suspended in one tenth of the original vol-
ume of Lysis Bu¡er. The cytosolic fraction was
concentrated using a Centricon-10 concentrator
Table 1
Sequences of the primers used for the detection by RT^PCR of mRNA encoding TRP proteins and glyceraldehyde 3-phosphate dehy-
drogenase (GAPDH) in rat brain, rat hepatocytes and liver cell lines
Primera Sequence Expected size of
PCR products (bp)
GenBank accession no.
Ref.
MTS 1 (TRP-1 sense) ATG GGA CAG ATG TTA CAA 400 U40980 (mTRP-1) [26]
MTS 2B (TRP-2 sense) CGC TGG GCA CTC TGC AGA 370 U40981 (mTRP-2) [26]
MTS 3 (TRP-3 sense) AGG ACA TAT TCA AGT TCA 340 U40982 (mTRP-3) [26]
MTS 4 (TRP-4 sense) CAG ATA TCT CTG GGA AGG ATG 400 X90697 (mTRP-4) [25]
MTS 5 (TRP-5 sense) TTC TCT TTA TCT ACT GCC 360 U40984 (mTRP-5) [26]
MTS 6 (TRP-6 sense) TTC ATG GTC ATA TTC ATC 320 U49069 (mTRP-6) [26]
MTA (common degenerate TGG AGC RAA YTT CCA YTCb J04844 (dTRP) [22]
antisense) M88185 (dTRPL) [23]
X90697 (mTRP-4) [25]
U31110 (hTRP-1) [24]
GAPDH: sense ACC ACA GTC CAT GCC ATC AC 450 M17701 (rGAPDH) [27]
GAPDH: antisense TCC ACC ACC CTG TTG CTG TA
aMTS, mouse TRP sense primer; MTA, mouse TRP antisense primer. Each TRP sense primer (MTS) was used in conjunction with
the common degenerate antisense primer MTA.
bR = G or A; Y = C or T.
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(Amicon, MA). Protein concentrations were deter-
mined by the Bradford method [29].
For Western blot analysis, protein extracts (40 Wg
protein) were subjected to 9% SDS^polyacrylamide
gel electrophoresis then transferred to a nitrocellu-
lose membrane (Hybond C+) by semi-dry blotting
(HorizBlot, Atto Corporation, Japan) [30]. The
membranes were blocked for 1 h at room temper-
ature with a solution composed of 20 mM Tris^
HCl (pH 8), 500 mM NaCl and 0.1% (v/v) Tween-
20 (TBS-T) which contained 5% (w/v) skim milk
powder, then incubated with the anti-TRP-1 poly-
clonal antibody (1 Wg/ml in TBS-T containing 3%
(w/v) skim milk powder) for 16 h at 4‡C, followed
by four washes (5 min each) with TBS-T. The sec-
ondary antibody, anti-rabbit IgG-peroxidase conju-
gate (1:2000 dilution in TBS-T containing 3% v/v
skim milk powder) was applied for 1 h at room tem-
perature followed by four washes with TBS-T.
Bound peroxidase was detected by enhanced chemi-
luminescence [31] (ECL, Western Blotting Detection
Reagents, Amersham), according to the manufactur-
er’s instructions, followed by exposure of the mem-
brane to X-Omat Blue XB-1 ¢lm. Where indicated,
the anti-TRP-1 antibody (1 Wg/ml) was blocked be-
fore use by incubation with antigenic peptide (1 Wg/
ml) for 2 h at 4‡C followed by centrifugation at
14 000Ug for 10 min at 4‡C in order to remove im-
mune complexes.
The relative amount of expressed hTRPC-1 pro-
tein in H4-IIE cells was estimated from the intensity
of the hTRPC-1 band (80 kDa) calculated by volume
integration using the GS-700 Imaging Densitometer
and Molecular Analyst Image Analysis Software
(Bio-Rad Laboratories, CA). In order to account
for variations in the amount of protein present on
the membrane, the intensity values were normalised
by expressing each band as a ratio of the intensity of
a non-speci¢c band (V50 kDa) (unrelated to TRP-1)
which was detected by the anti-TRP-1 antibody but
was not blocked by peptide.
2.6. Immunolocalisation of the hTRPC-1 protein
expressed in H4-IIE cells
H4-IIE cells expressing hTRPC-1 and EGFP,
grown on collagen-coated coverslips, were rinsed
with PBS and ¢xed with 4% (w/v) paraformaldehyde
in PBS for 30 min, rinsed with PBS, then permeabi-
lised with 1% (v/v) Triton X-100 in PBS for 4 min at
room temperature. Cells were again rinsed with PBS,
blocked with 20% (w/v) foetal bovine serum in PBS
for 1 h at room temperature, washed with PBS con-
taining 0.1% (v/v) Tween-20 (PBS-T), and incubated
for 2 h at room temperature with rabbit polyclonal
anti-TRP-1 antibody diluted 2 Wg/ml in PBS-T. The
cells were then washed with PBS-T and incubated for
1 h at room temperature in the dark with the sec-
ondary antibody, Cy3-conjugated anti-rabbit IgG at
1:200 dilution in PBS-T. After washing four times in
PBS-T, the coverslips were mounted on glass slides
and viewed using an Olympus AX70 £uorescence
microscope (40U objective lens) in conjunction
with a Hamamatsu ORCA cooled CCD camera.
The ¢lter blocks employed were Chroma 31001 NB
(excitation 470^490 nm, emission 515^545 nm) for
EGFP, Chroma 31002 (excitation 515^550 nm, emis-
sion 575^615 nm) for Cy-3.
2.7. Measurement of rates of Ca2+ and Mn2+ in£ow
Rates of Ca2 and Mn2 in£ow to H4-IIE cells
were estimated using intracellular fura-2. Cells sus-
pended in complete DMEM were plated onto circu-
lar collagen-coated [3] glass coverslips (22 mm diam-
eter, approximately 0.2U106 cells per coverslip) and
incubated for 24 h at 37‡C in an atmosphere of 5%
(v/v) CO2 in air in order to create a cell monolayer.
The cells were loaded with fura-2 by incubation of
the coverslip/H4-IIE cell monolayer with 10 WM
fura-2 acetoxymethylester in the presence of pluronic
F-127 acid (0.025% (v/v)) in DMEM containing bo-
vine serum albumin (2% w/v) for 30 min at 37‡C in
5% (v/v) CO2 in air. In some experiments (where
indicated), the incubation was performed for 1 h at
room temperature. The coverslip/H4-IIE cell mono-
layer was then washed twice at 37‡C in 116 mM
NaCl, 4.6 mM KCl, 1.2 mM MgSO4, 1.2 mM
KH2PO4, 25 mM NaHCO3, and 20 mM TES, ad-
justed to pH 7.4 with NaOH (modi¢ed Krebs^Hen-
seleit bu¡er), and mounted in a temperature-con-
trolled incubation chamber (Applied Imaging, UK)
placed on the microscope stage. Modi¢ed Krebs^
Henseleit bu¡er (with, or without, added Ca2 as
indicated in the legends to ¢gures) (300 Wl) was
then added to the incubation chamber. In experi-
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ments in which Mn2 in£ow was measured or in
which Gd3 was employed, the modi¢ed Krebs^Hen-
seleit bu¡er was replaced by a simpler HEPES-bu¡-
ered saline medium which was composed of 140 mM
NaCl, 5 mM KCl, 1 mM MgCl2, 10 mM D-glucose,
15 mM HEPES, and 1 mM CaCl2 (pH adjusted to
7.4 at 37‡C with NaOH).
Cell £uorescence was measured at 34‡C using an
inverted Nikon TMD-EF £uorescence microscope, a
20U objective lens or a 40U glycerol immersion ob-
jective lens, an intensi¢ed CCD camera (ISIS-3/S20,
Photonic Science) and Axon Imaging Workbench
(Version 2.2) software. For Ca2, excitation was at
340 and 380 nm and the ratio of £uorescence inten-
sity at 340 and 380 nm was determined. For Mn2,
an excitation wavelength of 360 nm was employed. A
Nikon UV ¢lter block was used to isolate emitted
light. Neutral density ¢lters (2.0, 2.3, 2.6 or 3.0, as
required) were incorporated into the excitation light
path in order to decrease photobleaching. Each cov-
erslip provided data from 25^50 di¡erent cells with
varying degrees of loading with fura-2. Cells which
exhibited initial (basal) £uorescence values below 100
and above 250 £uorescence ratio units were excluded
from subsequent analysis. For Ca2 measurements,
values of maximum (Rmax) and minimum (Rmin) £uo-
rescence ratio were estimated at the end of each ex-
periment by the addition of 10 WM ionomycin (in the
presence of 5 mM Ca2) and 20 mM EGTA (in 0.15
M Tris, pH 8.7), respectively, and were converted to
[Ca2]cyt [32] using a value of 224 nM for the Kd for
the association of Ca2 with fura-2 [1,32].
The location of fura-2 in the cytoplasmic space of
H4-IIE cells was veri¢ed as follows. Fura-2-loaded
cells were treated with digitonin (20 WM) to selec-
tively disrupt the plasma membrane but not intra-
cellular membranes [32]. This released 70^85% of
the cell-associated fura-2, indicating that the dye
was principally located in the cytoplasmic space.
This conclusion was con¢rmed by inspection of the
location of fura-2 £uorescence in images of fura-2-
loaded H4-IIE cells (results not shown). The possi-
bility that maitotoxin treatment increases the loss of
fura-2 from the cytoplasmic space [8], which would
in£uence the observed rate of Mn2-induced quench
of intracellular fura-2, was tested as follows. H4-IIE
cells loaded with fura-2 were incubated in the pres-
ence or absence of 600 pM maitotoxin and their £uo-
rescence measured (excitation wavelength 360 nm) as
a function of time for 20 min. Cells incubated in the
presence or absence of maitotoxin exhibited a loss of
8 þ 1% (n = 3) and 5.7 þ 0.3% (n = 6) of the initial val-
ue of £uorescence (about 200 £uorescence units), re-
spectively, during this time period. These results in-
dicate that maitotoxin does not induce a signi¢cant
loss of fura-2 from H4-IIE cells under the conditions
employed for the measurement of Ca2 and Mn2
in£ow.
In some experiments, Ca2 and Mn2 in£ow was
measured in cells co-transfected with DNA encoding
EGFP and hTRPC-1 (or empty vector). Although
there is a considerable di¡erence between the peak
excitation wavelengths for EGFP (488 nm) and fura-
2 (340 and 380 nm), it was possible that light emitted
from EGFP in cells loaded with fura-2 interferes with
the measurement of [Ca2]cyt and Mn2 in£ow. To
test this possibility, the £uorescence of cells express-
ing EGFP and of control cells (no EGFP) was mea-
sured at excitation wavelengths of 340 and 380 nm
(Ca2) and 360 nm (Mn2) using di¡erent neutral
density ¢lters and di¡erent gain settings for the
CCD camera. The results (not shown) indicate that
under the conditions employed for the measurement
of Ca2 and Mn2 in£ow in this study (neutral den-
sity ¢lters greater than 2 and camera settings which
minimise background £uorescence), the £uorescence
of EGFP makes a negligible contribution to the ob-
served fura-2 £uorescence emission.
Rates of Ca2 in£ow and amounts of Ca2 re-
leased from intracellular stores were estimated as de-
scribed previously [3]. Rates of Mn2 in£ow were
estimated from the maximum slope of plots of £uo-
rescence as a function of time following the addition
of Mn2 to cells loaded with fura-2. Results shown
in the ¢gures are the mean values obtained for the
number of cells indicated in one experiment, while
those in the tables and text are the means þ S.E.M.
of those obtained for the total number of cells and
number of separate experiments indicated. Degrees
of signi¢cance were determined using Student’s
t-test for unpaired or paired samples, as indicated.
2.8. Electrophysiology
Whole-cell patch clamping [33] was performed at
room temperature using a computer-based patch-
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clamp ampli¢er (EPC-9, HEKA Electronics, Ger-
many) and PULSE software (HEKA Electronics).
The usual bath solution contained (mM): NaCl,
140; CsCl, 4; CaCl2, 2; MgCl2, 2; and HEPES,
10; adjusted to pH 7.4 with NaOH. When the con-
centration of divalent cations was changed in the
external solution the concentration of NaCl was
changed accordingly on an iso-osmolar basis. Two
internal (pipette) solutions with di¡erent Ca2 bu¡-
ering capacities were employed. A strong Ca2 bu¡er
internal solution contained (mM): Cs glutamate,
120; CsCl, 10; MgATP, 2; EGTA, 10; and HEPES,
10; adjusted to pH 7.2 with KOH. A weak Ca2
bu¡er internal solution contained (mM): Cs gluta-
mate, 120; CsCl, 10; MgATP, 2; EGTA, 1; CaCl2
1; and HEPES, 10; adjusted to pH 7.2 with KOH.
The internal solutions were hypotonic compared with
the external solution in order to prevent the activa-
tion of volume-regulated Cl3 channels [5]. Depletion
of intracellular Ca2 stores was achieved by intra-
cellular perfusion with the strong Ca2 bu¡er inter-
nal solution.
Patch pipettes were pulled from borosilicate glass
coated with Sylgard and ¢re-polished: pipette resis-
tance ranged between 2 and 4 M6. In order to mon-
itor the development of the current, voltage ramps
between 3120 and +60 mV were applied every 2 s,
starting immediately after achieving the whole-cell
con¢guration. Early traces were used for leakage
subtraction. Acquired currents were ¢ltered at 2.7
kHz and sampled at 10 kHz. Traces presented in
the ¢gures were further digitally ¢ltered at 1.5 kHz.
All voltages shown are nominal voltages, and have
not been corrected for the liquid junction potential of
318 mV between the bath and electrode solutions
(estimated using the JPCalc programme [34]). The
holding potential was 0 mV throughout. Compensa-
tion for cell capacitance and series resistance was
made automatically by the EPC9 ampli¢er before
each voltage ramp. As described in Section 3, in cells
expressing hTRPC-1 maitotoxin initiated the activa-
tion of a large inward current which continued to
increase in magnitude with increasing time after mai-
totoxin addition and, in some cases, led to cell death.
For cells expressing hTRPC-1, the results presented
include only those obtained with cells in which it was
shown that the maitotoxin-initiated current could be
e¡ectively blocked by Gd3, Zn2 or Cd2. For all
patch-clamp recording data, unless otherwise speci-
¢ed, the results shown are the means þ S.E.M.
3. Results
3.1. Characterisation of maitotoxin-initiated divalent
cation in£ow in H4-IIE cells
In the presence of extracellular Ca2, a low con-
centration of maitotoxin (60 pM) caused a substan-
tial increase in [Ca2]cyt (Fig. 1A) (cf. [7]). The onset
of this e¡ect was slow, taking about 4 min to achieve
a maximal rate of increase in [Ca2]cyt. The addition
of maitotoxin to cells incubated in the absence of
added extracellular Ca2 caused no increase in
[Ca2]cyt indicating that maitotoxin does not induce
the release of Ca2 from intracellular stores (Fig.
1B). This was further investigated by determining
the amount of Ca2 released by thapsigargin added
6 min after the addition of 300 pM maitotoxin to
cells incubated in the absence of added Ca2. The
thapsigargin-induced increase in [Ca2]cyt (peak
height) was 0.063 þ 0.003 (n = 7) and 0.067 þ 0.002
(n = 9) £uorescence ratio units (Ps 0.05) in the ab-
sence and presence of maitotoxin, respectively. Tak-
en together, these results indicate that maitotoxin
does not cause the release of a signi¢cant amount
of Ca2 from intracellular stores in H4-IIE cells.
The subsequent addition of extracellular Ca2 to
cells incubated in the presence of maitotoxin and
absence of extracellular Ca2 caused a large increase
in [Ca2]cyt compared with the addition of Ca2 in
the absence of maitotoxin (Fig. 1B cf. A, and Table
2). Under the conditions employed (60^300 pM mai-
totoxin for 15 min), no obvious toxic e¡ects of mai-
totoxin were observed, as assessed by the examina-
tion of cell morphology and the ability of the cells to
retain fura-2. These results indicate that, as shown
previously [7] for freshly isolated rat hepatocytes,
maitotoxin initiates a signi¢cant increase in plasma
membrane Ca2 in£ow in H4-IIE cells without caus-
ing a detectable release of Ca2 from intracellular
stores. Maitotoxin-stimulated Ca2 in£ow was inhib-
ited by Gd3 with half-maximal inhibition at approx-
imately 1 WM Gd3 (Fig. 2). Within the range of
Gd3 concentrations tested (0.5^10 WM) the inhibi-
tion by Gd3 was not complete. Maitotoxin also
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Table 2
Maitotoxin and thapsigargin initiate the activation of Ca2 in£ow in control H4-IIE cells and in cells expressing hTRPC-1
Cells Agonist Ca2 in£ow initiated by extracellular Ca2 addition
Initial rate (nM/s) Value of plateau following
Ca2o addition (nM)
Transfected with cDNA encoding ^ ^ 94 þ 4 (94 cells)
EGFP alone Maitotoxin (60 pM) 2.87 þ 0.20 (109 cells) 699 þ 17 (109 cells)
Thapsigargin (10 WM) 17.8 þ 0.6 (336 cells) 775 þ 22 (336 cells)
Co-transfected with cDNA encoding ^ ^ 92 þ 6 (97 cells)
EGFP and hTRPC-1 Maitotoxin (60 pM) 5.64 þ 0.61* (73 cells) 1117 þ 78* (73 cells)
Thapsigargin (10 WM) 22.7 þ 0.7* (302 cells) 924 þ 11* (302 cells)
Cell transfection and the measurement of Ca2 in£ow were performed as described in Section 2 and in the legends of Figs. 1 and 8.
Maitotoxin and thapsigargin, when present, were added before extracellular Ca2 (5 mM). The values shown are the means þ S.E.M.
for the total number of cells indicated and were obtained from 4^9 separate experiments. The degree of signi¢cance, determined using
Student’s t-test for unpaired samples, for a comparison of the values obtained for cells expressing hTRPC-1 with the corresponding
value for control cells, is *P6 0.05. The degree of signi¢cance for a comparison of the values obtained in the presence of maitotoxin
or thapsigargin with the corresponding value in the absence of agonist is P6 0.01.
Fig. 1. Maitotoxin initiates the activation of Ca2 in£ow in control H4-IIE cells and in cells expressing hTRPC-1. (A,C) The e¡ect of
maitotoxin (MTX) added after extracellular Ca2 to control cells (transfected with cDNA encoding EGFP) (A) or to cells co-trans-
fected with cDNA encoding EGFP and hTRPC-1 (C). (B,D) The e¡ect of maitotoxin added before the addition of extracellular Ca2
to control cells (transfected with cDNA encoding EGFP) (B) or to cells co-transfected with cDNA encoding EGFP and hTRPC-1
(D). The times of addition of maitotoxin (MTX, 60 pM) and Ca2 (5 mM) are indicated by the arrows. The traces shown are the
means of those obtained from 17 (A), 20 (B), 19 (C) and 13 (D) cells in one experiment in each case, and are representative of the
traces obtained in each of 4^9 separate experiments.
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caused a substantial increase in the rate of Mn2-
induced quenching of intracellular fura-2 when
added 6 min before the addition of Mn2 (Fig. 3
(control cells) and Table 3) (cf. [7]).
3.2. Detection of a maitotoxin-induced Na+ current by
patch-clamp recording
In whole cell patch-clamp recordings in which the
pipette solution contained a strong Ca2 bu¡er (10
mM EGTA) maitotoxin failed to induce any current
(n = 9) within 10 min. When the pipette solution con-
tained a weak Ca2 bu¡er (1 mM EGTA and 1 mM
Ca2), application of 60 pM maitotoxin in the exter-
nal solution for 2^3 min activated an inward current
(Fig. 4A). The average maximal amplitude at 3100
mV was 320 þ 67 pA (n = 11). The reversal potential
of the maitotoxin-activated current was about +10
mV and was not a¡ected by varying the Cl3 concen-
tration, indicating that the current activated by mai-
totoxin is a cation current. After reaching its maxi-
mal amplitude the maitotoxin-activated current
declined slowly but could be repeatedly re-activated
by the application of maitotoxin for 2^3-min periods.
The maitotoxin-induced current was blocked by
Fig. 3. Maitotoxin stimulates Mn2 in£ow in control H4-IIE cells and in cells expressing hTRPC-1. (A) The addition of Mn2 in the
absence of maitotoxin to control cells (transfected with cDNA encoding EGFP and empty pcDNA3 vector) (upper trace) and cells
co-transfected with cDNA encoding EGFP and hTRPC-1 (lower trace). (B) The addition of Mn2 following pre-treatment with maito-
toxin (MTX) to control cells (transfected with cDNA encoding EGFP and empty vector) (upper trace) and cells co-transfected with
EGFP and hTRPC-1 (lower trace). The times of addition of maitotoxin (MTX, 300 pM) and Mn2 (100 WM) are indicated by the ar-
rows. Mn2 in£ow was measured as described in Section 2 using the HEPES-bu¡ered saline medium. The traces shown are the means
of those obtained from 23 (A, control) and 17 (A, hTRPC-1), and 17 (B, control) and 22 (B, hTRPC-1) cells in one experiment in
each case, and are representative of the traces obtained in each of ¢ve separate experiments.
Fig. 2. Dose^response curves for the inhibition by Gd3 of mai-
totoxin-initiated Ca2 in£ow (measured using fura-2) in control
H4-IIE cells and in cells expressing hTRPC-1. Initial rates of
Ca2 in£ow were measured in control cells (co-transfected with
empty cDNA encoding EGFP and pcDNA3 vector) (closed
circles) and in cells co-transfected with cDNA encoding EGFP
and hTRPC-1 (open circles) in experiments similar to those
shown in Fig. 1B,D as described in Section 2 using the
HEPES-bu¡ered saline medium. The results are the means
þ S.E.M. (n = 3^6 independent experiments).
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concentrations of Gd3 in the micromolar range with
half-maximal inhibition at 1.3 þ 0.1 WM (n = 4) (Fig.
4A,B,F). The block by 100 WM Gd3 was not com-
plete leaving a residual component of 10^30% of the
initial amplitude of the current. This residual com-
ponent was not a¡ected by the replacement of Na
by Tris, suggesting that maitotoxin initiates the ac-
tivation of both a Gd3-sensitive and a Gd3-insen-
sitive NSCC or that the residual Gd3-insensitive
component represents a non-speci¢c leakage through
the plasma membrane which has developed after the
addition of maitotoxin. The Gd3-sensitive compo-
nent of the maitotoxin-initiated current was also sen-
sitive to the concentration of Ca2 in the external
solution. An increase in the Ca2 concentration
from 2 mM to 10 mM caused an approximately
50% reduction of the current amplitude (results not
shown). At 100 mM external Ca2 there was no de-
tectable Gd3-sensitive current and the reversal po-
tential of the residual current was shifted toward
negative potentials (Fig. 4B). Moreover, in the pres-
ence of 100 mM extracellular Ca2 the outward cur-
rent was also reduced (Fig. 4B). These observations
indicate that extracellular Ca2 inhibits the maitotox-
in-activated channel and suggest that, compared to
Na, both Ca2 conductance and Ca2 permeability
through the maitotoxin-activated channel are low.
3.3. Identi¢cation of mRNA encoding TRP proteins 1,
2 and 3 in H4-IIE cells and rat hepatocytes
Since it has been shown that TRP proteins, when
expressed heterologously, form non-selective cation
channels [26,35^37], experiments were directed to-
wards identifying which of the TRP proteins 1^6
are expressed in liver cells, using RT^PCR as de-
scribed in Section 2. PCR bands corresponding to
the expected sizes of the ampli¢ed sequences for
TRP proteins 1^6 were detected in rat brain
mRNA, as shown previously [16,38] (Fig. 5 and Ta-
ble 4). In mRNA from H4-IIE cells, the AML12
mouse liver cell line, and rat hepatocytes, PCR bands
corresponding to the expected sizes of the ampli¢ed
sequences for TRP proteins 1, 2 and 3, but not
to TRP proteins 4, 5 and 6, were detected (Fig. 5
and Table 4). cDNA encoding the TRP-1 protein
was detected with two separate primer sets, MTS
1/MTA (Fig. 5A) and MTS 2B/MTA (Fig. 5B),
although the second was with reduced e⁄ciency.
The detection of cDNA encoding TRP-1 by the sec-
Fig. 4. Maitotoxin initiates the activation of inward currents in control H4-IIE cells and in cells expressing hTRPC-1. (A) Time course
of inward current development in control H4-IIE cells (co-transfected with cDNA encoding EGFP and empty pcDNA3 vector) after
the addition of 60 pM maitotoxin (MTX) to the external solution, and inhibition of the current by Gd3. Each point on the trace
represents the amplitude of the current at 3100 mV taken from the current responses to the voltage ramps (3120 to +60 mV) applied
every 2 s after establishing the whole cell con¢guration. The horizontal bars show the times of application of maitotoxin and solutions
containing Gd3. The plot shown represents the results obtained for one of 15 cells which each gave similar results. (B) Instantaneous
current^voltage relationship in the range 3100 to +60 mV obtained for control cells in response to a voltage ramp at the time of
maximal inward current development after maitotoxin addition to the control external solution, or where 140 mM extracellular Na
was replaced with 100 mM Ca2, or in control external solution in the presence of 10 WM Gd3. The plots shown represent the re-
sults obtained for one of seven cells which each gave similar results. (C) Time course of inward current development in H4-IIE cells
expressing hTRPC-1 (co-transfected with cDNA encoding EGFP and hTRPC-1) after the addition of 60 pM maitotoxin (MTX) to
the external solution, and inhibition of the current by Gd3. The plot shown represents the results obtained for one of nine cells
which each gave similar results. Experimental details are as described in A. Note that the scale for the ordinate in C is much smaller
than that for the ordinate in A. (D) Instantaneous current^voltage relationship in the range 3100 to +60 mV obtained for cells ex-
pressing hTRPC-1 in response to a voltage ramp at the time of maximal inward current development after maitotoxin addition to the
control external solution, or where 140 mM extracellular Na was replaced with 100 mM Ca2, or in control external solution in the
presence of 10 WM Gd3. The plots shown represent the results obtained for one of ¢ve cells which each gave similar results. (E) Am-
plitudes of the currents measured at 3100 mV activated by maitotoxin in the control cells (co-transfected with cDNA encoding
EGFP and empty pcDNA3 vector) (n = 11) and in cells expressing hTRPC-1 (co-transfected with cDNA encoding EGFP and hTRPC-
1) (n = 17). (F) Dose-dependent inhibition of the maitotoxin-induced inward current by Gd3 in the control cells transfected with
empty pcDNA3 vector (open symbols) and cells expressing hTRPC-1 (¢lled symbols). The current amplitude at 3100 mV obtained at
various external Gd3 concentrations was normalised to the control current obtained in the absence of Gd3. The results are the
means þ S.E.M. Sigmoidal dose^response curves were ¢tted to the data with an o¡set, and a Hill coe⁄cient of 1. The ¢t gave a Kd of
1.3 þ 0.1 WM (n = 4) for control cells and 3.3 þ 0.2 WM (n = 4) for cells expressing hTRPC-1.
C
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ond primer set is likely to be due to partial homology
between MTS 2B and TRP-1 cDNA.
The abundance of the mRNA encoding TRP pro-
teins 1, 2, and 3 in the liver cells compared with the
abundance of the corresponding mRNA in rat brain
was estimated using a strategy of limiting dilution
PCR, using mRNA encoding glyceraldehyde 3-phos-
phate dehydrogenase as a reference. The abundance
of TRP-1 mRNA was similar in all three liver cell
types investigated, and similar to that in brain (Table
4). On the other hand, the abundance of TRP-2 in
the liver cell lines was less than that in brain. The
abundance of TRP-3 was more variable between the
di¡erent liver cell types, and was lower than that in
brain (Table 4).
Sequencing of the PCR products showed that the
TRP-1, TRP-2 and TRP-3 fragments detected in rat
liver are s 99% homologous (at the DNA level) with
the corresponding rat TRP-1, -2 and -3 cDNA se-
quences in GenBank (accession numbers: AF061266
[39], AF136401 [40], AB022331 [41], respectively).
3.4. Heterologous expression of the hTRPC-1 protein
in H4-IIE cells
In order to further test the idea that a TRP protein
Table 4
The size and limits of detection of the PCR products obtained by amplifying cDNA derived from mRNA encoding TRP proteins 1^6
in liver cells and rat brain
PCR primer Highest dilution of cDNA from which PCR product was detected
H4-IIE cells Rat hepatocytes AML12 cells Rat brain
TRP-1 1/10 000 1/10 000 1/10 000 1/10 000
TRP-2 1/10 1/5 1/10 1/33
TRP-3 1/10 1/33 1/33^1/100 1/100
TRP-4 No product No product No product 1/10
TRP-5 No product No product No product 1/33^1/100
TRP-6 No product No product No product 1/100
GAPDH 1/100 000 1/100 000 1/100 000 1/10 000^1/100 000
Values are the highest dilution of cDNA from which PCR product could be detected as a visible band by ethidium bromide staining
in agarose gel after 45 cycles of ampli¢cation (GAPDH 35 cycles). The results were obtained from at least three ampli¢cations from
each of two (brain, AML12) or three (hepatocytes, H4-IIE) separate preparations of cDNA of each cell type. Where results were vari-
able, a range of dilutions is given. Comparisons can be made horizontally between cell types, but not vertically between TRP types as
the products were ampli¢ed using di¡erent primer sets. No bands were observed with any of the primer sets when reverse transcrip-
tase was omitted from the reaction mixture for cDNA synthesis thus excluding the possibility that the PCR products were ampli¢ed
from contaminating genomic DNA.
Table 3
Maitotoxin initiates Mn2 in£ow in control H4-IIE cells and in cells expressing hTRPC-1
Cells Rate of Mn2 in£ow (£uorescence units/min)
Basal Maitotoxin present Maitotoxin-stimulated
rate
Co-transfected with cDNA encoding EGFP and
empty pcDNA3 vector
6.1 þ 0.3 (119 cells) 12.9 þ 0.5 (97 cells) 6.7 þ 0.5 (5)
Co-transfected with cDNA encoding EGFP and
hTRPC-1
10.7 þ 0.5 (92 cells)* 21.5 þ 1.3 (99 cells)** 10.8 þ 1.1 (5)*
Cell transfection and the measurement of Mn2 in£ow (in HEPES-bu¡ered saline medium) were performed as described in Section 2
and in the legend of Fig. 3. The maitotoxin-stimulated rate of Mn2 in£ow was calculated for each separate experiment (n = 5) by
subtracting the basal rate of Mn2 in£ow from that observed in the presence of maitotoxin. Maitotoxin, when present, was added
6 min before Mn2 (100 WM). The values are the means þ S.E.M. for the total number of cells indicated and were obtained from ¢ve
separate experiments. The degrees of signi¢cance, determined using Student’s t-test for paired samples, for a comparison of the values
obtained for cells expressing hTRPC-1 with the corresponding value for control cells are *P90.05 and **P90.01.
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is the molecular correlate of the maitotoxin-initiated
cation channel in H4-IIE cells, the hTRPC-1 protein
was expressed in these cells. The predicted amino
acid sequence of hTRPC-1 is 99% identical to that
of rat TRP-1L [40]. This TRP protein was selected
because, of the seven known animal cell TRP pro-
teins, it is widely expressed in non-excitable animal
cells [16]. H4-IIE cells were transiently co-transfected
with cDNA encoding EGFP and hTRPC-1, and
GFP £uorescence used to assess transfection e⁄cien-
cies and to identify individual transfected cells. From
the proportion of cells expressing EGFP, the e⁄-
ciency of the transient transfection was estimated to
be about 5^10%. The degree of expression of the
hTRPC-1 protein in a population of co-transfected
H4-IIE cells was assessed using Western blot analy-
sis. In cell extracts, a band with an apparent molec-
ular mass of about 80 kDa, which was not present in
extracts of control cells, was observed using a poly-
clonal antibody raised against a peptide correspond-
ing to the 18 amino acids at the carboxy terminus of
TRP-1 (Fig. 6A, lane 2 cf. lane 1). Appearance of
this 80 kDa band was prevented when the anti-TRP-
1 antibody was blocked with the antigenic peptide
(Fig. 6A, lane 4 cf. lane 2). Analysis of proteins ex-
tracted from H4-IIE cells expressing hTRPC-1 at
several time points after transient transfection
showed that the intensity of the 80 kDa band, but
not that of the other bands, increased to a maximum
at about 24 h, then declined (Fig. 6B,C).
The size (80 kDa) of the hTRPC-1 protein ex-
pressed in H4-IIE cells is smaller than the predicted
size (87 kDa) [17] for hTRPC-1 and the estimated
size (92 kDa) of the band attributed to the expressed
hTRP-1 protein in extracts of COS cells transfected
with DNA encoding hTRP-1 [40]. However, it cor-
responds to the observed size (80 kDa) of TRPC-1
expressed in insect Sf9 cells [35] and hTRPC-1 ex-
pressed in Xenopus oocytes [28], and endogenous
TRP-1 in Xenopus oocytes [28]. Bands of 100, 110
and approximately 200 kDa were also detected in
both control and co-transfected H4-IIE cells (Fig.
6A, lanes 1 and 2). These may represent proteins
which contain epitopes which bind the anti-TRP-1
antibody but are not components of the TRP-1 pro-
tein.
Examination of the intracellular location of ex-
pressed hTRPC-1 showed that most of the expressed
protein is located in interior regions of the cell. Fig.
7A,B show a ¢eld of 11 cells of which three exhibited
EGFP £uorescence (Fig. 7A) and hTRPC-1 immu-
no£uorescence (Fig. 7B). A control image in which
the anti-hTRPC-1 antibody was replaced by pre-im-
mune serum is shown in Fig. 7C. Most of the ex-
pressed hTRPC-1 protein appears to be located in
the ER and the Golgi networks, some at the plasma
membrane, and none in the nucleus (Fig. 7B). In
order to determine whether the majority of the
hTRPC-1 protein is present in cellular membranes,
subcellular fractionation and Western blot analysis
Fig. 5. PCR products ampli¢ed from mRNA isolated from H4-IIE cells, rat hepatocytes (Hep), the AML12 mouse liver cell line
(AML) and rat brain using RT^PCR and primers corresponding to sequences of cDNA encoding TRP proteins 1, 2, and 3. The prim-
ers (Table 1) were: MTS 1/MTA, selective for TRP-1 (A); MTS 2B/MTA, selective for TRP-2, but also ampli¢ed TRP-1 (B); and
MTS 3/MTA, selective for TRP-3 (C). The sizes of the PCR products are: 400 bp (A, TRP-1); 370 bp and 430 bp (B, TRP-2 and
TRP-1, respectively); and 340 bp (C, TRP-3). Other bands in B and C were shown by DNA sequencing to be non-speci¢c products
unrelated to TRP. The unmarked lanes contain SPP1/EcoRI DNA size markers. The results shown are representative of those ob-
tained in one of three similar experiments.
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were conducted. The results indicate that all the ex-
pressed hTRPC-1 protein is located in cellular mem-
branes (Fig. 7D).
The detection of hTRPC-1 by immuno£uorescence
was also used to estimate the extent of hTRPC-1
expression as a function of time after transient
transfection of the cells. At 24 h after co-transfection
with cDNA encoding EGFP and hTRPC-1 about
40% of the cells which exhibited EGFP £uorescence
also expressed the hTRPC-1 protein. At 48 h,
the number of cells expressing hTRPC-1 had de-
creased to about 20% of the cells which expressed
EGFP.
3.5. Enhancement of maitotoxin-initiated Ca2+ and
Mn2+ in£ow in H4-IIE cells heterologously
expressing hTRPC-1
Maitotoxin-initiated Ca2 in£ow was greatly en-
hanced in cells expressing hTRPC-1 (Fig. 1D cf. B,
and Table 2). In the Ca2 add-back protocol, the
initial rate of Ca2 in£ow and the magnitude of the
subsequent plateau of [Ca2]cyt were enhanced by
about 100% and 60%, respectively, in cells expressing
hTRPC-1. hTRPC-1 expression did not detectably
enhance Ca2 in£ow in the absence of maitotoxin
(Fig. 1C cf. A, and Table 2). When maitotoxin was
added to cells initially incubated in the presence of
extracellular Ca2, the maitotoxin-induced plateau of
[Ca2]cyt was increased by 60% in cells expressing
hTRPC-1 compared with control cells (Fig. 1C cf.
A). The value of the plateau reached after maitotoxin
addition was 440 þ 23 (94 cells) and 921 þ 16 (97
cells) nM (P90.05, unpaired t-test) for control cells
(transfected with EGFP) and cells transfected with
hTRPC-1, respectively. The dose^response curve for
the inhibition by Gd3 of maitotoxin-induced Ca2
in£ow in cells expressing hTRPC-1 was determined
and compared with that for non-transfected cells
(Fig. 2). In cells transfected with hTRPC-1, the con-
Fig. 6. The detection by Western blot analysis of the expressed hTRPC-1 protein in H4-IIE cells transfected with cDNA encoding
hTRPC-1. (A) Proteins extracted from cells co-transfected with cDNA encoding EGFP and hTRPC-1 and control cells (transfected
with cDNA encoding EGFP). For the two lanes marked ‘peptide block’, the anti-TRP-1 antibody was pre-incubated with blocking
peptide as described in Section 2. (B) Proteins extracted from H4-IIE cells expressing hTRPC-1 at di¡erent times after co-transfection
of the cells with cDNA encoding EGFP and hTRPC-1. The times elapsed (h) after cell transfection are indicated for each lane. (C) A
plot of the relative intensity of the 80 kDa hTRPC-1 band in B as a function of time. The intensity of the 80 kDa band is expressed
as a ratio of the intensity of the 50 kDa band (indicated by the arrow in B) in order to take into account variations in the amounts
of protein applied to the gel and transferred from the gel to the membrane. The results shown are those obtained for each of 10 (A,
lanes 1 and 2), 2 (A, lanes 3 and 4), and 2 (B,C) experiments which each gave similar results.
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centration of Gd3 which gave half-maximal inhibi-
tion was approximately 1 WM which is comparable
with that obtained for control cells (transfected with
empty vector). As observed for control cells, inhibi-
tion of maitotoxin-initiated Ca2 in£ow in cells ex-
pressing hTRPC-1 was not complete.
Cells expressing hTRPC-1 exhibited a 70% en-
hancement of basal Mn2 in£ow (Fig. 3A and Table
3) and a 60% enhancement of maitotoxin-stimulated
Mn2 in£ow (Fig. 3B cf. A, and Table 3). hTRPC-1
expression also enhanced thapsigargin-stimulated
Ca2 in£ow by about 20% (Fig. 8 and Table 2) but
did not a¡ect thapsigargin-induced release of Ca2
from intracellular stores.
3.6. Analysis of cells expressing hTRPC-1 by
patch-clamp recording
In cells transfected with hTRPC-1 and with weak
Ca2 bu¡er in the pipette, maitotoxin (60 pM) acti-
Fig. 7. Intracellular location of the expressed hTRPC-1 protein in H4-IIE cells. (A) A high-resolution £uorescence microscope image
of a ¢eld of 11 cells co-transfected with cDNA encoding EGFP and hTRPC-1 showing three cells expressing EGFP. (B) Image of the
same ¢eld of cells as in A showing Cy3 £uorescence (indicating the expression of hTRPC-1) for the three cells in A which exhibit
GFP £uorescence. (C) Image of Cy3 £uorescence of a ¢eld of cells co-transfected with cDNA encoding EGFP and hTRPC-1 under
conditions where the anti-TRP-1 antibody was replaced by pre-immune rabbit serum. The results shown in A^C are representative of
those obtained in three separate transient transfection experiments. Scale bar = 10 Wm. (D) Western blot analysis of a membrane and
a cytosolic fraction from cells expressing hTRPC-1. Preparation of the membrane and cytosolic fractions and Western blot analysis
were conducted as described in Section 2. The results shown are those obtained from one of two Western blots performed on mem-
brane fractions from one transient transfection experiment.
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vated a signi¢cantly larger cation current than that
observed in non-transfected cells (Fig. 4C cf. A, and
Fig. 4E). (The current amplitude scale for Fig. 4C is
much smaller than that for Fig. 4A) In the absence
of maitotoxin, no current was detected over a time
period of 1000 s. Moreover, no maitotoxin-activated
current was observed in cells transfected with
hTRPC-1 with the strong Ca2 bu¡er in the pipette.
When the maitotoxin was washed out, the amplitude
of the current in hTRPC-1 transfected cells kept in-
creasing (Fig. 4C), frequently resulting in the cell
death. The maitotoxin-initiated current in hTRPC-
1-transfected cells was blocked by Gd3 with half-
maximal inhibition at 3.4 þ 0.3 WM (n = 4; Fig.
4C,D,F). The current was also partially blocked by
Zn2 and Cd2 in the range 1^10 mM (results not
shown). The average maximal amplitude of the mai-
totoxin-initiated current in hTRPC-1 transfected cells
was 4.9 þ 1.3 nA (n = 11) at 3100 mV. When the
external solution contained 100 mM Ca2, the cur-
rent^voltage plot was identical to that obtained using
normal external solution (140 mM Na) (Fig. 4D).
Thus, unlike the cation channels activated by maito-
toxin in non-transfected cells, channels in hTRPC-1
transfected cells showed no block by extracellular
Ca2 and the same permeability for Ca2 as for
Na. Application of the external solution which con-
tained 100 mM Ca2 for more than 2 min resulted in
a further increase of the current amplitude to values
that could not be properly clamped by the ampli¢er
(results not shown).
TRP-1 is considered to be one of the candidates
for a store operated Ca2 channel [37,42^44]. It has
previously been shown, using patch-clamp recording,
that H4-IIE cells possess store-operated Ca2 chan-
nels which have a very high selectivity for Ca2 com-
pared with Na and are indistinguishable from the
Ca2 release-activated Ca2 channels (CRAC chan-
nels) well characterised in lymphocytes and mast cells
[2]. The possibility that hTRPC-1 is a store-operated
Ca2 channel in H4-IIE cells was investigated by
depleting internal Ca2 stores using a strong Ca2
bu¡er pipette solution. In hTRPC-1 transfected cells,
this resulted in activation of a Ca2-selective current
which was identical in magnitude to the store-oper-
ated Ca2 current (ICRAC) observed previously in
non-transfected H4-IIE cells [2] (n = 8, results not
shown). There was no evidence for the activation
of any other type of store-operated Ca2 channel
in cells transfected with hTRPC-1.
4. Discussion
4.1. Characteristics of the maitotoxin-activated
endogenous cation channel in H4-IIE cells
The results obtained using fura-2 and patch-clamp
Fig. 8. Thapsigargin initiates the activation of Ca2 in£ow in H4-IIE cells expressing hTRPC-1. The times of addition of thapsigargin
(10 WM) and Ca2 (5 mM) to control cells (transfected with cDNA encoding EGFP) and cells co-transfected with cDNA encoding
EGFP and hTRPC-1 are shown by the arrows. The traces shown are the means of those obtained from 24 (A) and 44 (B) cells in
one experiment in each case, and are representative of the traces obtained in each of nine separate experiments.
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recording indicate that maitotoxin initiates the acti-
vation of a cation channel which admits Na, Ca2
and Mn2 ; has a high selectivity for Na compared
with Ca2 ; is inhibited when the extracellular Ca2
concentration is increased; and is inhibited by Gd3
at concentrations in the micromolar range. The ob-
servation that channels are not activated when the
cytoplasmic space is perfused with a strong Ca2
bu¡er (10 mM EGTA) indicates that the process
by which the channel is activated requires at least a
basal level of [Ca2]cyt. These properties, together
with knowledge of the mechanism of action of mai-
totoxin on cells [7^13] and the absence of evidence
for maitotoxin-induced cell toxicity and cell lysis (cf.
results obtained for some other cell types [8]) suggest
that the maitotoxin-activated NSCCs are endoge-
nous liver cell channels.
The likely steps (cf. [7^13]) in the process by which
maitotoxin activates NSCCs in H4-IIE cells are: the
binding of the toxin to a speci¢c protein on the plas-
ma membrane [13] or possibly insertion of the hydro-
phobic polycyclic ether moieties of the toxin into the
plasma membrane to create a non-speci¢c pore
which admits Na and Ca2 and other cations; in-
creases in the intracellular concentrations of Na
and Ca2 ; activation of endogenous NSCCs; and
in£ow of Na and Ca2 through endogenous
NSCCs. The toxin may activate both a Gd3-sensi-
tive and a Gd3-insensitive NSCC. Alternatively,
Gd3-insensitive component of maitotoxin-stimu-
lated Ca2 and Na in£ow may represent movement
of the cations through the pore formed by maitotox-
in itself whereas the Gd3-sensitive component most
likely represents endogenous maitotoxin-activated
NSCCs. It is considered unlikely that the process
by which maitotoxin activates Ca2 and Na in£ow
in H4-IIE cells involves the release of Ca2 from the
endoplasmic reticulum (cf. results reported by others
for ¢broblasts [8,45]) since no evidence was obtained
in the present experiments to indicate that maitotox-
in induces Ca2 release from intracellular stores. A
noticeable feature of the action of maitotoxin is the
relatively slow time of onset for the activation of
Ca2 in£ow (cf. [7]). This may be due to a slow
accumulation of the toxin in the plasma membrane
and/or to the insertion of endogenous NSCC pro-
teins into the plasma membrane (cf. [9]).
Several properties of the maitotoxin-activated
NSCC, including the block by extracellular Ca2,
high permeability for Na, permeability to Mn2
as well as Ca2, and inhibition of Na in£ow when
the extracellular Ca2 concentration is increased are
similar to properties reported for mast cell receptor-
activated NSCCs [46]. These channels can be acti-
vated by agonists and the secretagogue 48/80, have
a conductance of 50 pS, principally admit Na but
can also admit Ca2 and Mn2, are inhibited by
protein kinase C and by the movement of Ca2
through the channel, and play a role (in conjunction
with store-operated Ca2 channels) in regulating
[Ca2]cyt [46].
4.2. Endogenous TRP proteins expressed in liver cells
The results of the RT^PCR experiments indicate
that mRNA encoding TRP proteins 1, 2 and 3 is
expressed in freshly isolated rat hepatocytes, a rat
liver cell line (H4-IIE) and a mouse liver cell line
(AML12). The results obtained using limiting dilu-
tion PCR indicate that the level of expression of
TRP-1 mRNA in liver cells is comparable with that
in brain. The inability to detect the endogenous
TRP-1 protein by Western blot or immuno£uores-
cence is most likely due to a relatively low a⁄nity
of the anti-TRP-1 antibody employed for the TRP-1
protein (T.K. Chataway, H. Brereton, G.J. Barritt,
unpublished results). The conclusion that TRP pro-
teins 1 and 3 are expressed in liver cells is consistent
with the observations of others who have reported
the detection of mRNA encoding the TRP-1
[17,38,39,47,48] and TRP-3 [38] proteins in liver us-
ing RT^PCR or Northern blot analysis, and detec-
tion of the TRP-1 protein in Xenopus oocyte liver
[48].
4.3. Characteristics of the maitotoxin-activated cation
in£ow through the heterologously expressed
hTRPC-1 protein
The immuno£uorescence and Western blot results
obtained with H4-IIE cells heterologously expressing
hTRPC-1 indicate that, while some of the expressed
protein is located at the plasma membrane, a consid-
erable amount is located in intracellular membranes.
Further evidence for the location of some expressed
hTRPC-1 in the plasma membrane is provided by
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results of the patch-clamp recording experiments
which clearly demonstrate the appearance of a new
type of current in cells expressing hTRPC-1. Corre-
lation of the immuno£uorescence results (present
study) with the intracellular location of the endoplas-
mic reticulum in H4-IIE cells [3] suggests that con-
siderable amounts of hTRPC-1 are located in the
endoplasmic reticulum and Golgi networks. Similar
observations of an intracellular location of heterolo-
gously expressed TRP-1 have been made by others
with other cell types [37,40]. Expressed hTRPC-1
may accumulate in the endoplasmic reticulum and
Golgi because the cells are synthesising amounts of
the hTRPC-1 protein which are well in excess of the
quantities normally processed and tra⁄cked to the
plasma membrane (cf. regulation of the translocation
from intracellular compartments to the plasma mem-
brane of growth factor-regulated channel (a member
of the TRP family of proteins) induced by insulin-
like growth factor-1 [49], and K channels expressed
in Xenopus oocytes [50]). Three other explanations
for the presence of expressed hTRPC-1 in the endo-
plasmic reticulum and Golgi are (i) recycling of plas-
ma membrane hTRPC-1 back to the endoplasmic
reticulum via endosomes and endocytosis, (ii) mis-
targeting of the hTRPC-1 protein in the environment
of the liver cell (a highly polarised epithelial cell in
which mechanisms which ensure the correct targeting
of plasma membrane proteins are complex [51,52]),
and (iii) the possibility that endogenous TRP-1 and
heterologously expressed hTRPC-1 are located at the
endoplasmic reticulum so that they can exert a phys-
iological function at this site. At present, these pos-
sible explanations cannot be eliminated.
The heterologous expression of hTRPC-1 caused
an enhancement of maitotoxin-initiated Ca2 and
Mn2 in£ow and the appearance of a large maito-
toxin-initiated current with properties which di¡er
from those of the maitotoxin-initiated current ob-
served in control cells. The maitotoxin-activated
channel in cells expressing hTRPC-1 is characterised
by an approximately equal permeability to Ca2 and
Na and inhibition by Gd3 (half-maximal inhibi-
tion at 3 WM Gd3). These properties are similar to
those reported by others for TRP-1 heterologously
expressed in other cell types [35,36,38]. Since the ap-
pearance of this current was dependent on expression
of hTRPC-1 it can be concluded that it is mediated
by the presence of hTRPC-1 polypeptides in the plas-
ma membrane either as a homo- or hetero-tetramer
(e.g. composed of hTRPC-1 and one or more endog-
enous channel-forming polypeptides). Another possi-
bility which cannot be excluded is that expression of
hTRPC-1 induces the ‘upregulation’ or activation of
an endogenous channel which is not otherwise acti-
vated by maitotoxin.
If maitotoxin can initiate the activation of ex-
pressed hTRPC-1, and control H4-IIE cells express
the endogenous TRP-1 protein, it would be expected
that maitotoxin could also activate endogenous
TRP-1 leading to the appearance of a current with
the characteristics of the hTRPC-1 current in control
cells. The failure to detect such a current in control
cells may be because (i) the amount of endogenous
TRP-1 protein is low and hence the associated cur-
rent is masked by the endogenous maitotoxin-acti-
vated NSCC current, and/or (ii) the endogenous
TRP-1 polypeptides form heterotetramers with other
channel-forming peptides to yield a channel with
properties which di¡er from those of hTRPC-1 ho-
motetramers which may form when hTRPC-1 is
over-expressed.
The observations that the maitotoxin-initiated in-
ward current observed in cells expressing hTRPC-1
does not develop when the cells are perfused with a
strong intracellular Ca2 bu¡er and increases dra-
matically when 100 mM Ca2 is present in the extra-
cellular medium for a prolonged period of time sug-
gest that, in the environment of H4-IIE cells,
expressed hTRPC-1 is activated by an increase in
[Ca2]cyt. Although initiation of the activation of
the hTRPC-1 channel depends on the presence of
maitotoxin, further activation occurred in the ab-
sence of the toxin. Such an ‘autocatalytic’ activation
could be due to the e¡ect of an increase in [Ca2]cyt
on a Ca2-activated hTRPC-1 channel or a maito-
toxin-induced insertion of hTRPC-1 polypeptides
into the plasma membrane (cf. the suggestion that
maitotoxin induces the insertion of cation channels
into the Xenopus oocyte plasma membrane [9]).
Recently it has been shown using patch-clamp re-
cording that H4-IIE cells possess a highly Ca2-se-
lective store-operated Ca2 channel which is indistin-
guishable from the Ca2 release-activated Ca2
channels (CRAC channels) in lymphocytes and
mast cells [2]. Moreover, studies which have em-
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ployed 2-aminoethyl phenylborate (2-APB) as an in-
hibitor of store-operated Ca2 channels suggest that
CRAC-like channels are the predominant store-oper-
ated Ca2 channel in H4-IIE cells [53]. In the present
study, no evidence was obtained to indicate that
hTRPC-1 expression enhances the inward current
due to Ca2 in£ow through the CRAC-like channels
in H4-IIE cells. Moreover, the cation speci¢city of
the hepatocyte store-operated Ca2 channel [2] is
very di¡erent from that of the hTRPC-1 channel
(present results). Thus it can be concluded that
hTRPC-1 is unlikely to be the major liver cell
store-operated Ca2 channel.
On the basis of di¡erences in cation speci¢city and
susceptibility to inhibition by Gd3 of the endoge-
nous maitotoxin-activated NSCC and the expressed
hTRPC-1 protein, it is concluded that it is unlikely
that the endogenous TRP-1 protein is the molecular
counterpart of the maitotoxin-activated endogenous
NSCC in H4-IIE cells. Further experiments are re-
quired to elucidate the functions of the TRP-1 pro-
tein and the TRP-2 and -3 proteins in liver cells.
Their functions may include the regulation of liver
cell volume and shape (cf. [5]). Experiments directed
towards elucidation of the functions of TRP-1 will be
aided by the observation that maitotoxin is an e¡ec-
tive initiator of hTRPC-1 channel activation.
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